產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CYT 19抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CYT 19抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CYT 19
Cat. Number:
Anti-CYT 19抗體KL-10633R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Formation of methylated metabolites is a critical step in the metabolism of inorganic arsenic. Arsenite methyltransferase (cyt19) is localized to the cytoplasm and operates in the transfer of a methyl group from AdoMet Anti-CYT 19抗體to trivalent arsenicals producing methylated and dimethylated arsenicals. It methylates arsenite to form methylarsonate which is reduced to methylarsonite. Methylarsonite acts as a substrate and is converted into a much less toxic compound dimethylarsinate. cyt19 is highly expressed in liver. Inherited variation in cyt19 may contribute to variation in arsenic metabolism and possibly arsenic-dependent carcinogenesis in humans.
Also known as:
2310045H08Rik; CYT19; Anti-CYT 19抗體Arsenic (+3 oxidation state) methyltransferase; Arsenite methyltransferase; As3mt; AS3MT_HUMAN; C10ORF32; CYT19; Cyt19 protein; Hypothetical protein C10orf32; Methylarsonite methyltransferase; Methyltransferase cyt19; OTTHUMP00000020384; RP11-753C18.6; S adenosylmethionine arsenic (III) methyltransferase; S-adenosyl-L-methionine:arsenic(III) methyltransferase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit, Sheep, hu, mo, rat, cow, hrs, chk, shp, dog, Rb.
●
Immunogen: KLH conjugated Anti-CYT 19抗體synthetic peptide derived from human CYT 19.
●
Predicted Molecular Weight: 42kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-CYT 19抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl616Hu01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Mu01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl616Ra01 V-Rel網(wǎng)狀內(nèi)皮增生病毒癌基因同源物A(RELA)多克隆抗體 Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (RELA)
kl618Hu01 速激肽受體2(TACR2)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl618Mu01 速激肽受體2(TACR2)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl618Ra01 速激肽受體2(TACR2)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 2 (TACR2)
kl620Hu01 解整合素金屬蛋白酶8(ADAM8)多克隆抗體 Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl620Mu01 解整合素金屬蛋白酶8(ADAM8)多克隆抗體 Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl620Ra01 解整合素金屬蛋白酶8(ADAM8)多克隆抗體 Polyclonal Antibody to A Disintegrin And Metalloprotease 8 (ADAM8)
kl622Hu01 谷胱甘肽S轉(zhuǎn)移酶θ1(GSTθ1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 1 (GSTt1)
kl622Mu01 谷胱甘肽S轉(zhuǎn)移酶θ1(GSTθ1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 1 (GSTt1)
kl622Ra01 谷胱甘肽S轉(zhuǎn)移酶θ1(GSTθ1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Theta 1 (GSTt1)
kl623Hu01 谷胱甘肽S轉(zhuǎn)移酶ω1(GSTω1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Omega 1 (GSTo1)
kl623Mu01 谷胱甘肽S轉(zhuǎn)移酶ω1(GSTω1)多克隆抗體 Polyclonal Antibody to Glutathione S Transferase Omega 1 (GSTo1)
kl624Hu01 肝癌源性生長(zhǎng)因子(HDGF)多克隆抗體 Polyclonal Antibody to Hekloma Derived Growth Factor (HDGF)
kl624Mu01 肝癌源性生長(zhǎng)因子(HDGF)多克隆抗體 Polyclonal Antibody to Hekloma Derived Growth Factor (HDGF)
kl624Ra01 肝癌源性生長(zhǎng)因子(HDGF)多克隆抗體 Polyclonal Antibody to Hekloma Derived Growth Factor (HDGF)
